Shanghai Fosun Pharmaceutical Group Co. Ltd.
Division of Fosun International Ltd.
www.fosunpharma.com/en
Latest From Shanghai Fosun Pharmaceutical Group Co. Ltd.
Asia Deal Watch: ReVance Licenses Chinese Rights To Botox Competitor To Fosun
With Phase III data in 2,800 patients for reducing frown lines, ReVance anticipates filing RT002 for US approval in 2019. ABL licenses two bispecific antibody candidates to TRIGR, while Sun looks to expand in dermatology with Pola buyout.
Finance Watch: Not Everyone Can Go Public, But Biopharma IPOs Are Using Multiple Markets
Not every drug developer can go public, but biopharma IPOs are launching in multiple markets, including Moderna's prospective $500m US offering and Innovent's $421m Hong Kong IPO. Also, Sarepta prices a $500m FOPO and Omeros sells $210m in notes.
Asia Deal Watch: Alvotech Signs On To Biosimilar Manufacturing JV In China
With partner CCHN, Alvotech will help finance construction of a biologics facility in Changchun, China. Novartis will work with Cellular Biomedicine to produce Kymriah for China, and will gain access to its CAR-T platform.
Deal Watch: Opportunity Knocks For Partnerships In Asia
ApolloBio signs on to take Inovio's HPV immunotherapy into China and Senju and Fosun sign China partnerships – all part of a wave of Chinese companies looking to bring innovative new medicines to the Greater China markets. Meanwhile, GSK signs on with Indian CRO Syngene.
Company Information
- Industry
- Distributors
- In Vitro Diagnostics
- Medical Devices
-
Pharmaceuticals
- Vaccines
-
Research, Analytical Equipment & Supplies
- PCR & Amplification Tools
- Therapeutic Areas
- Cancer
- Cardiovascular
- Gastrointestinal
- Infectious & Viral Diseases
- Metabolic Disorders
- Neurology, Nervous System
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
Asia
-
China
-
China
-
Asia
- Parent & Subsidiaries
-
Fosun International Ltd.
-
Shanghai Fosun Pharmaceutical Group Co. Ltd.
- Breas Medical AB
- Chongqing Fochon Pharmaceutical Research Co. Ltd.
- Hunan Dongting Pharmaceutical Co. Ltd.
- Jinzhou Ahon Pharmaceutical Co Ltd.
- Shanghai Chemo Wanbang Biopharma Co. Ltd.
- Shanghai Fosun Long March Medical Science Co. Ltd.
- Suzhou Erye Pharmaceutical Co. Ltd.
- Wanbang Biopharmaceuticals Ltd.
-
Shanghai Fosun Pharmaceutical Group Co. Ltd.
- Senior Management
-
Wu Yifang, Pres. & CEO
Guan Xiaohui, SVP, CFO
Shao Ying, VP, Dir, R&D - Contact Info
-
Shanghai Fosun Pharmaceutical Group Co. Ltd.
Phone: (86) 21 33987000
1289 Yishan Rd.
Bldg. A
Shanghai , 200233
China
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice